Therefore, this study explored the feasibility of abnormal methylation of the GRHL2 gene promoter region in patients with acute leukemia and cell lines as hematologic markers and further studied the demethylation of the GRHL2 gene by arsenide trioxide and 5-azacitidine. This evidence concerns the gene GRHL2 and acute leukemia.